Doc Abode is a real-time clinician deployment platform. It dynamically matches patient need to available clinical capacity, helping NHS services respond faster and keep people out of hospital.
A 50% increase in Urgent Community Response service capacity and workforce productivity, and agency spend eliminated at a leading London-based provider.
In 2026 Doc Abode secured IP-backed growth funding from NatWest, a loan that unlocks the value of the company’s intellectual property. It will help Doc Abode invest in implementation capacity, customer success and ongoing product development as it supports more NHS trusts. As Taz puts it: “As a GP, I’ve seen the human cost of poor coordination… This funding accelerates our ability to scale a better way of working.”
Read more: Health tech platform Doc Abode secures NatWest IP-backed growth funding (NatWest Group).
Founder and CEO Dr Taz Aldawoud is named one of the Ones to Watch in the LDC Top 50 2026, supported by The Times.
Founded in 2016 by Dr Taz Aldawoud, a GP. Backed by NatWest IP-backed growth funding, SBRI Healthcare, the AWS Healthcare Accelerator and the Momentum Fund. Doc Abode was part of the Techcelerate Health Tech Cluster.
1 post mentioning Doc Abode.
Join tech founders who put execution before investment.